SJShaji Thomas John

Shaji Thomas John

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shaji Thomas John has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Kizhanipurath Gayathri

    Down Syndrome Clinic, Department of Pediatrics, Baby Memorial Hospital, Calicut, Kerala, India

    3 shared publications
  • Abhay M. Martin

    Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India

    1 shared publication
  • Anup Jayaram

    Manipal Institute of Virology Manipal Academy of Higher Education, Manipal Udupi Karnataka India

    1 shared publication
  • C. J. Michael

    Department of ENT, Government General Hospital, Kozhikode, Kerala, India

    1 shared publication
  • Cecylia Francis Meshy

    Parenting for Autism Network Dar es Salaam Tanzania

    1 shared publication
  • Devis Sindano

    L’Arche Association of Calgary Calgary Canada

    1 shared publication

Latest Publications

  • Consensus Statement of the Neurodevelopmental Pediatrics Chapter of Indian Academy of Pediatrics (IAP) on the Management of Children With Down Syndrome

    by Shaji Thomas John, Kizhanipurath Gayathri, Shabina Ahmed, Kawaljit Singh Multtani, Puthezhath Shankar Narayanan Menon, Raman Krishna Kumar, Vaikom Hariharan Sankar, Prajnya Ranganath, Neerja Gupta, Mohandas Nair, et al.

    Justification The diagnosis of Down syndrome (DS) is easily made clinically but the management is multi-disciplinary and life-long. There is no standard protocol available for its management in India. Process A committee was formed under the Indian Academy of Pediatrics (IAP) chapter of Neuro developmental pediatrics consisting of 20 experts working in the related field. The various aspects of the condition were discussed and allotted to the concerned experts related for preparing the guidelines. The material received was collated to form a set of guidelines, which were reviewed by the committee, and a consensus statement made. The guidelines were then approved by the chapter, and by the IAP. Objectives To define the condition and to look into the various aspects of antenatal and postnatal diagnosis. To explain briefly about the involvement of the various systems that are involved and formulate recommendations for management. To recommend early and sustained interventional therapies to enable children with DS lead an independent life. Recommendations The stress on bio-psycho-social strategy for the management of children with DS is reiterated, and the need for a medical, social and rights model is recommended after each section. The age-wise recommendations are also highlighted in addition to the recommendations under each system.


  • Screening of mothers to detect Down syndrome: a practical approach in a resource limited setting

    by Shaji Thomas John, Kizhanipurath Gayathri

    Background: Advanced maternal age, history of abortion and/or bleeding in pregnancy are risk factors for the birth of a chromosomally abnormal child. This study was done to find out their relationship especially in Down syndrome (DS).Methods: Retrospective observational study was done in children with DS and their mothers, from a major referral institution in India over a period of 20 years. The prevalence of abortion/bleeding in pregnancy with the age of mothers were analysed using statistical package for social sciences (SPSS) V20 software and compared in all the cytogenetic profiles.Results: In mothers less than 35 years 21.8% had abortion, 8% had bleeding and 4.5% had both abortion and bleeding. In mothers more than 35 years 25% had abortion, 7.3% had bleeding and 4% had both abortion and bleeding. Thus 34.5% had abortion/bleeding in mothers less than 35 years and 36.8% in those above 35 years. 15.25% mothers were more than 35 years. When the individual cytogenetic pattern and the prevalence of abortion/bleeding were analysed in maternal age group less than 35 years; a higher prevalence was seen in the non-disjunction group (34.2%), followed by translocation (24%) and mosaic (21.42%). In maternal age group >35 years prevalence was high, though not statistically significant, in the mosaic group (66.67%) followed by non-disjunction (43%).Conclusions: Mothers with a history of abortion/bleeding and those above 35 years constituted 44.7%. Ideally all pregnant women should be screened for chromosomal aneuploidies, but in resource limited countries screening should be done at least in the above noted high risk groups.


  • Key learnings from COVID‐19 to sustain quality of life for families of individuals with IDD

    by Rachael Wanjagua, Stevie‐Jae Hepburn, Rhonda Faragher, Shaji Thomas John, K. Gayathri, Margaret Gitonga, Cecylia Francis Meshy, Lucena Miranda, Devis Sindano

    COVID‐19 has very publicly had profound impacts on the health system of every country in the world. Over 4.5 million people have lost their lives. School closures worldwide where up to 1.6 billion of the world’s children have been out of school, are also prominent in world news. Behind these public impacts are the families. In this paper, we focus on the experiences of families with people with intellectual and developmental disabilities (IDD) through analysis of two data sets: the emerging research literature and contributions from our author team who have lived experience of intellectual and developmental disability in the context of COVID‐19. From these two data sets, we discern five themes of the impact of the pandemic: on health, on education, on services and supports, on families and finally on relationships beyond the family. We conclude with lessons from those living with intellectual and developmental disabilities, the carers and the individuals themselves to draw implications for supporting families in the context of disability during future pandemics.


  • Cytogenetic Patterns, Congenital Heart Disease, and Thyroid Dysfunction in Children with Down Syndrome

    by Shaji Thomas John, Kizhanipurath Gayathri, Kalpathy Vaidyanathan Sahasranam


  • Open Access

    Reactive infectious mucocutaneous eruptions associated with SARS-CoV-2 infection

    by Shaji Thomas John, Gayathri K., Rizwana P., Abhay M. Martin

    Several dermatological manifestations are described in COVID-19. A 3-year-old boy presented with fever, painful oral ulcers with COVID-19 infection. A diagnosis of reactive infectious mucocutaneous eruptions (RIME) was made. He was worked up for the usual causes of RIME but were all negative. His severe acute respiratory syndrome corona virus-2 immunoglobulin M (SARS-CoV-2 IgM) was positive and he was managed with Intravenous hydrocortisone with which he improved dramatically. RIME might be the first/only manifestation of COVID-19 and it should be kept in mind.

  • Open Access

    Genetic analysis of Enterovirus D68 associated with pneumonia in children from South India

    by Ramachandran Erathodi Sanjay, Sasidharanpillai Sabeena, Sudandiradas Robin, John T. Shaji, M. P. Jayakrishnan, E. K. Kumar Suresh, C. J. Michael, S. Aswathyraj, Joseph Josmi, Sheik Shahin, et al.

    EV-D68 is an emerging enterovirus infection associated with severe acute respiratory illness (SARI), acute flaccid myelitis (AFM) and acute flaccid paralysis (AFP). While EV-D68 outbreaks and sporadic cases are reported globally, a single case has been reported from India. The present study aims to investigate the molecular epidemiology and clinical characteristics of EV-D68-associated SARI cases from South India. We screened influenza-negative archived throat swab specimens from Influenza-Like Illness (ILI) and SARI cases (n=959; 2016 to 2018 period) for enteroviruses by pan-enterovirus real-time RT-PCR. Thirteen samples positive for enteroviruses were typed by PCR and sequencing based on VPI, VP2 and/or 5′NCR regions. One EV-D68 RNA sample was subjected to next-generation sequencing for whole genome characterisation. Among 13 enterovirus cases, four were ECHO-11, three EV-D68, two CV-A16 and one each EV-71, CV-B1, CV-B2 and CV-A9. All three cases of EV-D68 infection were reported in children below 2 years of age from Kerala state of South India during June and July 2017. The patients developed pneumonia without any neurological complications. Sequencing based on VPI and 5′NCR regions showed that EV-D68 strains belong to the novel subclade B3. The EV-D68 complete genome identified with two unique amino acid substitutions in VP1 (T-246-I) and 3D (K-344-R) regions. This study reiterates the EV-D68 novel subclade B3 circulation in India and indicates the urgent need for structured EV-D68 surveillance in the country to describe the epidemiology.